Modern Vaccines Adjuvants and Delivery Systems (MVADS)
Monday, September 9 –  Wednesday, September 11

Freiburgstrasse 18
3010 Bern, Switzerland

Join Dr. Annie De Groot (CEO/CSO) and Dr. Paul von Hoegen (European Representative) as they attend the Modern Vaccines Adjuvants and Delivery Systems conference September 9-11 in Inselspital, Universitatsspital, Bern, Switzerland. EpiVax will present their latest research in vaccine development on day one of the conference, during Session 4. The title of the presentation is as follows: “Pathogens engineer tolerance: Can immune-engineered vaccines outsmart them?



The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This new international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research.

There is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 2019 will offer researchers a fresh forum to discuss this important topic in detail.

MVADS 2019 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.

Scientific sessions will include:

  • Mechanistic interpretations
  • Delivery
  • Formulation and design
  • Modern vaccines and adjuvants
  • Safety
  • Regulation
  • Future developments

To learn more about the conference and/or to RSVP, visit MVADS’ official event page.